Picture of Regeneron Pharmaceuticals logo

REGN — Regeneron Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

US FDA approves Sanofi's genetic disorder drug

 US FDA approves Sanofi's genetic disorder drug

- The US FDA on Wednesday approved Sanofi's SASY.PA oral drug venglustat, making it the first treatment for a type of rare genetic condition that affects the brain and nervous system, the health regulator said.




(Reporting by Kamal Choudhury in Bengaluru and Bhanvi Satija in London; Editing by Sahal Muhammed)

((Kamal.Choudhury@thomsonreuters.com;))

Recent news on Regeneron Pharmaceuticals

See all news